MeiraGTx Holdings Plc

Perceptive Advisors’ new 1.16% stake in MeiraGTx boosts its capital for gene‑therapy pipelines, while warrant dynamics and insider trades signal potential upside for investors.

Insightful look at MeiraGTx insider sales: CFO’s 56k share sell in April raises questions about executive confidence amid volatile stock price.

MeiraGTx insider activity shows executives buying and selling shares around the market price, indicating confidence in the company’s gene‑therapy pipeline and a cautious optimism for future growth.